How We Treat Diseases With Our Stem Cell Therapy?
Treatment at EmCell clinic is a complex therapy combining fetal stem cell treatment and conventional
therapy. These methods are the latest achievements in modern medicine.
Fetal stem cell treatment presupposes transplantation of progenitor cells capable to form pools of cells responsible for certain systems and functions of the body: nervous, immune, and muscular systems, hematopoiesis, blood circulation, etc. Fetal stem cell transplantation is minimally invasive procedure presupposing minor intervention into the patient’s body, as it is conducted intravenously drip-feed or subcutaneously.
For our treatment, we use different types of stem cells harvested from various germ layers of the legally aborted embryos of 5–8 weeks of gestation, as these cells are characterized by specific therapeutic effects. Significant results in treatment have been achieved due to combination of different types of stem cells considering the disease process.
Stem Cell Therapy For Ischemic Heart Disease at EmCell, Ukraine
Transplantation of fetal stem cell suspensions in rehabilitation period in postinfarction cardiosclerosis and hypertension patients has positive effects on overall health as well as on rheological (flow) properties of blood. These effects have been proved by clinical data of postinfarction and other ischemic heart disease patients followed up at EmCell clinic.
When using fetal cell suspensions containing stem cells, syndrome of early
posttransplantation improvements is observed in all patients. The major manifestations of this syndrome include decreased weakness, improved overall health and appetite, normalized sleep formula, positive changes in psychoemotional sphere, such as reduced manifestation of somatic depression, improved emotional state, thinking, memory and hope for recovery. 80% of patients report gradual decrease of blood pressure, at first, taking the pretransplantation dose of antihypertensive drugs, but 2-4 weeks after the stem cell transplantation, 45-50% of patients reduce the dose of nitrates and antihypertensive drugs. Also, in all cases observed is gradual decrease and normalization of cholesterol, triglycerides, as well as low and very low density lipoproteins levels. Almost all our patients improve rheological properties of blood that can be related to the increase in prothrombin index and prolongation of coagulation time.
Due to formation of the alternative (additional) systems of collateral vessels in the cardiac muscle, tissue trophism significantly improves, manifestations of ischemia become less expressed, frequency and intensity of angina attacks decrease, and metabolism in myocardium improves.
Improvement in overall health and better ability to work motivate patients to extend their physical activities and return to their working career. All this taken as a whole improves life quality of ischemic heart disease patients and significantly (by 35%) extends their life span.
Curative Effects of Fetal Stem Cell Treatment
After administration into the patient’s body, fetal stem cells migrate to the site of damage, engraft, multiplicate, undergo specialization regulated by the new host (recipient), substitute lost or damaged cells, and restore the cell mass and impaired body functions. Moreover, stem cells we use produce necessary biologically active substances (e.g. hematopoietic growth factors, interleukins, nerve growth factor, tumour necrosis factor, angiogenic and neurotrophic factors etc.). Unlike adult stem cells, fetal cells we use are not rejected by the recipient due to the late expression of histocompatibility antigen.
Main effects observed in patients after fetal stem cell transplantation encompass all levels of organization and functioning of human body, and are arranged in a systemic way. We distinguished the following major curative effects of fetal stem cell transplantation:
